Jyong Biotech director reports 3,000 MENS shares

Jyong Biotech Ltd. director Hsu Ming Tsan filed an initial statement of beneficial ownership.

Accepted by SEC EDGAR 04/01/2026 - 03:43 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Jyong Biotech Ltd. director Hsu Ming Tsan filed an initial statement of beneficial ownership. The filing reports direct ownership of 3,000 shares of Common Stock. This Form 3 is a disclosure of existing holdings and does not show any recent purchase or sale activity.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Hsu Ming Tsan

Role Director

Type	Security	Shares	Price	Value
Holding	Common Stock	--	--	--

Holdings: Common Stock — 3,000 shares (Direct)

Key Figures

Directly owned shares: 3,000 shares

1 metrics

Directly owned shares 3,000 shares Common Stock held by director after reported holdings

Key Terms

Form 3, beneficial ownership, Common Stock

3 terms

Form 3 regulatory

"director Hsu Ming Tsan filed an initial statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"filed an initial statement of beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Common Stock financial

"The filing reports direct ownership of 3,000 shares of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MENS Form 3 filing by Hsu Ming Tsan show?

The Form 3 shows that director Hsu Ming Tsan beneficially owns 3,000 shares of Common Stock of Jyong Biotech Ltd. It is an initial ownership report rather than a record of a new transaction.

Did Hsu Ming Tsan buy or sell MENS shares in this Form 3?

The filing does not report any buy or sell transaction. It simply lists that 3,000 Common Stock shares are owned directly, serving as an initial disclosure of holdings as a company insider.

How many Jyong Biotech (MENS) shares does Hsu Ming Tsan own?

According to the Form 3, 3,000 shares of Common Stock are held directly by director Hsu Ming Tsan. This figure reflects ownership reported as of the filing’s effective reporting date.

What is the significance of a Form 3 for MENS investors?

Form 3 provides an initial snapshot of insider ownership when a person becomes a director, officer, or large shareholder. Here it shows that director Hsu Ming Tsan holds 3,000 Common Stock shares of Jyong Biotech Ltd.

Is the ownership in the MENS Form 3 direct or indirect?

The Form 3 indicates direct ownership of the reported shares. All 3,000 Common Stock shares are listed under direct ownership for director Hsu Ming Tsan, with no derivative positions disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hsu Ming Tsan

(Last) (First) (Middle)

23F-3, NO.95, SEC. 1, XINTAI 5TH RD.

(Street)

NEW TAIPEI CITY TAIWAN, PROVINCE OF CHINA 221

(City) (State) (Zip)

TAIWAN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026

3. Issuer Name and Ticker or Trading Symbol
Jyong Biotech Ltd. [ MENS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Hsu Ming Tsan	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)